 Natalie Nokoff
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transgender Persons | 12 | 2024 | 172 | 4.730 |
Why?
| | Adrenal Hyperplasia, Congenital | 12 | 2025 | 37 | 4.540 |
Why?
| | Disorders of Sex Development | 11 | 2021 | 38 | 2.230 |
Why?
| | Testosterone | 9 | 2025 | 372 | 2.190 |
Why?
| | Gender Dysphoria | 5 | 2024 | 19 | 1.340 |
Why?
| | Gonadotropin-Releasing Hormone | 3 | 2024 | 204 | 1.200 |
Why?
| | Estradiol | 5 | 2025 | 494 | 1.110 |
Why?
| | Cardiovascular Diseases | 4 | 2025 | 2003 | 1.050 |
Why?
| | Mental Disorders | 4 | 2025 | 1028 | 1.050 |
Why?
| | Neurodevelopmental Disorders | 3 | 2025 | 155 | 0.970 |
Why?
| | Insulin Resistance | 3 | 2020 | 1165 | 0.940 |
Why?
| | Androgen Antagonists | 1 | 2025 | 79 | 0.900 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 49 | 0.890 |
Why?
| | Genitalia | 6 | 2021 | 30 | 0.840 |
Why?
| | Puberty | 3 | 2024 | 143 | 0.830 |
Why?
| | Glomerular Filtration Rate | 2 | 2025 | 711 | 0.760 |
Why?
| | Athletic Performance | 1 | 2023 | 77 | 0.760 |
Why?
| | Adrenal Insufficiency | 2 | 2021 | 32 | 0.720 |
Why?
| | Genital Diseases, Female | 2 | 2021 | 27 | 0.710 |
Why?
| | Caregivers | 5 | 2022 | 808 | 0.690 |
Why?
| | Mood Disorders | 1 | 2021 | 120 | 0.690 |
Why?
| | Kidney | 3 | 2025 | 1385 | 0.690 |
Why?
| | Adolescent | 25 | 2025 | 20303 | 0.670 |
Why?
| | Male | 44 | 2025 | 63501 | 0.650 |
Why?
| | Female | 51 | 2025 | 68543 | 0.650 |
Why?
| | Body Composition | 2 | 2020 | 649 | 0.630 |
Why?
| | Emergency Service, Hospital | 2 | 2024 | 1896 | 0.620 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 566 | 0.620 |
Why?
| | Urogenital Surgical Procedures | 3 | 2020 | 5 | 0.620 |
Why?
| | Anxiety | 4 | 2023 | 962 | 0.610 |
Why?
| | Parents | 8 | 2022 | 1308 | 0.610 |
Why?
| | Child | 29 | 2025 | 20773 | 0.610 |
Why?
| | Turner Syndrome | 4 | 2023 | 51 | 0.590 |
Why?
| | Gonadal Steroid Hormones | 1 | 2019 | 131 | 0.590 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 17 | 0.530 |
Why?
| | Hypertension | 2 | 2022 | 1242 | 0.520 |
Why?
| | Humans | 59 | 2025 | 129248 | 0.520 |
Why?
| | Biomarkers | 4 | 2025 | 3966 | 0.500 |
Why?
| | Case-Control Studies | 5 | 2025 | 3377 | 0.490 |
Why?
| | Child, Preschool | 14 | 2025 | 10456 | 0.470 |
Why?
| | Emergencies | 1 | 2014 | 155 | 0.410 |
Why?
| | Electronic Health Records | 4 | 2025 | 970 | 0.410 |
Why?
| | Klinefelter Syndrome | 2 | 2025 | 56 | 0.400 |
Why?
| | Ambulatory Care Facilities | 1 | 2014 | 226 | 0.380 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5045 | 0.370 |
Why?
| | Body Mass Index | 1 | 2020 | 2272 | 0.370 |
Why?
| | Acute Disease | 1 | 2014 | 978 | 0.360 |
Why?
| | Obesity | 3 | 2022 | 2879 | 0.360 |
Why?
| | Sexual Development | 6 | 2023 | 18 | 0.350 |
Why?
| | Infant | 11 | 2025 | 8975 | 0.340 |
Why?
| | Glucocorticoids | 2 | 2025 | 578 | 0.330 |
Why?
| | Propensity Score | 2 | 2021 | 263 | 0.330 |
Why?
| | Insulin | 1 | 2019 | 2325 | 0.310 |
Why?
| | Odds Ratio | 2 | 2021 | 1018 | 0.300 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 386 | 0.290 |
Why?
| | Sex Characteristics | 3 | 2023 | 736 | 0.290 |
Why?
| | Androstenedione | 2 | 2024 | 11 | 0.280 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 757 | 0.280 |
Why?
| | Gender Identity | 4 | 2024 | 117 | 0.270 |
Why?
| | Genetic Predisposition to Disease | 3 | 2019 | 2276 | 0.260 |
Why?
| | Logistic Models | 2 | 2021 | 1984 | 0.260 |
Why?
| | Autoimmunity | 1 | 2012 | 862 | 0.250 |
Why?
| | Pediatrics | 1 | 2014 | 1047 | 0.250 |
Why?
| | Quality of Life | 7 | 2021 | 2685 | 0.250 |
Why?
| | Longitudinal Studies | 5 | 2024 | 2716 | 0.250 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2013 | 3628 | 0.250 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 1276 | 0.240 |
Why?
| | Mineralocorticoids | 1 | 2025 | 8 | 0.240 |
Why?
| | Sex Chromosome Aberrations | 2 | 2025 | 63 | 0.230 |
Why?
| | Sex Chromosome Disorders | 1 | 2025 | 20 | 0.230 |
Why?
| | Prospective Studies | 6 | 2025 | 7121 | 0.230 |
Why?
| | Familial Hypophosphatemic Rickets | 1 | 2024 | 6 | 0.220 |
Why?
| | Amines | 1 | 2024 | 37 | 0.220 |
Why?
| | Trisomy | 1 | 2025 | 77 | 0.220 |
Why?
| | Hypophosphatemia | 1 | 2024 | 17 | 0.220 |
Why?
| | Thiazoles | 1 | 2024 | 117 | 0.220 |
Why?
| | Genitalia, Female | 2 | 2021 | 38 | 0.220 |
Why?
| | Endometriosis | 1 | 2024 | 46 | 0.210 |
Why?
| | Primary Health Care | 1 | 2014 | 1678 | 0.210 |
Why?
| | Risk Factors | 5 | 2021 | 9745 | 0.210 |
Why?
| | Infant, Newborn | 3 | 2025 | 5736 | 0.210 |
Why?
| | Neonatal Screening | 1 | 2025 | 163 | 0.210 |
Why?
| | Testosterone Congeners | 1 | 2022 | 8 | 0.200 |
Why?
| | Leuprolide | 1 | 2022 | 19 | 0.200 |
Why?
| | Uncertainty | 2 | 2020 | 116 | 0.190 |
Why?
| | Androgens | 1 | 2023 | 178 | 0.190 |
Why?
| | Oxygen Consumption | 1 | 2024 | 672 | 0.180 |
Why?
| | Wnt4 Protein | 1 | 2021 | 18 | 0.180 |
Why?
| | Monosomy | 1 | 2021 | 11 | 0.180 |
Why?
| | Cardiology | 1 | 2024 | 261 | 0.180 |
Why?
| | Adaptation, Psychological | 2 | 2016 | 614 | 0.180 |
Why?
| | Overweight | 2 | 2022 | 531 | 0.180 |
Why?
| | Decision Making | 3 | 2022 | 849 | 0.170 |
Why?
| | Young Adult | 6 | 2023 | 12388 | 0.170 |
Why?
| | Dyslipidemias | 1 | 2022 | 177 | 0.170 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 135 | 0.170 |
Why?
| | Sex Hormone-Binding Globulin | 1 | 2019 | 53 | 0.160 |
Why?
| | Inservice Training | 1 | 2020 | 112 | 0.160 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 81 | 0.160 |
Why?
| | Growth Hormone | 1 | 2019 | 96 | 0.160 |
Why?
| | Sexual Maturation | 1 | 2019 | 52 | 0.160 |
Why?
| | Liver Diseases | 1 | 2022 | 290 | 0.160 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2019 | 810 | 0.160 |
Why?
| | Athletes | 1 | 2023 | 409 | 0.160 |
Why?
| | Capillaries | 1 | 2019 | 103 | 0.160 |
Why?
| | Suicidal Ideation | 1 | 2024 | 463 | 0.160 |
Why?
| | Postmenopause | 1 | 2021 | 350 | 0.160 |
Why?
| | Vascular Malformations | 1 | 2019 | 50 | 0.160 |
Why?
| | Reproductive Health | 1 | 2019 | 83 | 0.150 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2021 | 151 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2021 | 332 | 0.150 |
Why?
| | Developmental Disabilities | 1 | 2021 | 261 | 0.150 |
Why?
| | Adult | 11 | 2025 | 35495 | 0.150 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2021 | 163 | 0.150 |
Why?
| | Women's Health | 1 | 2021 | 364 | 0.150 |
Why?
| | Mentors | 1 | 2020 | 178 | 0.150 |
Why?
| | Mitochondria | 1 | 2024 | 877 | 0.150 |
Why?
| | Erythrocytes | 1 | 2023 | 673 | 0.140 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 251 | 0.140 |
Why?
| | Interprofessional Relations | 1 | 2020 | 275 | 0.140 |
Why?
| | Parent-Child Relations | 2 | 2019 | 256 | 0.140 |
Why?
| | Mentoring | 1 | 2020 | 127 | 0.140 |
Why?
| | Suicide | 1 | 2024 | 580 | 0.140 |
Why?
| | Emotional Adjustment | 1 | 2017 | 16 | 0.140 |
Why?
| | Anxiety Disorders | 2 | 2023 | 350 | 0.140 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 52 | 0.140 |
Why?
| | Sexual and Gender Minorities | 1 | 2021 | 195 | 0.140 |
Why?
| | Metformin | 1 | 2021 | 315 | 0.140 |
Why?
| | Diabetic Nephropathies | 1 | 2020 | 284 | 0.140 |
Why?
| | Linear Models | 1 | 2019 | 819 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 757 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2019 | 474 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2019 | 1288 | 0.130 |
Why?
| | Students, Medical | 1 | 2021 | 315 | 0.130 |
Why?
| | Perception | 1 | 2018 | 337 | 0.130 |
Why?
| | Hemodynamics | 1 | 2021 | 1090 | 0.130 |
Why?
| | Databases, Factual | 1 | 2021 | 1266 | 0.130 |
Why?
| | Adipose Tissue | 1 | 2020 | 590 | 0.130 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 508 | 0.120 |
Why?
| | Urologic Surgical Procedures | 1 | 2016 | 107 | 0.120 |
Why?
| | Hypopituitarism | 1 | 2015 | 16 | 0.120 |
Why?
| | Hypoglycemia | 1 | 2019 | 427 | 0.120 |
Why?
| | Pilot Projects | 1 | 2020 | 1584 | 0.120 |
Why?
| | Prognosis | 2 | 2020 | 3772 | 0.120 |
Why?
| | Hospitalization | 1 | 2024 | 2052 | 0.120 |
Why?
| | Stress, Psychological | 2 | 2019 | 1065 | 0.110 |
Why?
| | Sex Factors | 1 | 2019 | 1965 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4886 | 0.110 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5382 | 0.100 |
Why?
| | Age Factors | 1 | 2019 | 3140 | 0.100 |
Why?
| | Depressive Disorder | 1 | 2015 | 366 | 0.100 |
Why?
| | HLA Antigens | 1 | 2013 | 234 | 0.090 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2022 | 56 | 0.080 |
Why?
| | Blood Glucose | 1 | 2019 | 2097 | 0.080 |
Why?
| | Colorado | 1 | 2019 | 4406 | 0.080 |
Why?
| | Postoperative Complications | 2 | 2018 | 2473 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2449 | 0.080 |
Why?
| | Aged | 2 | 2025 | 22032 | 0.070 |
Why?
| | Middle Aged | 3 | 2025 | 31087 | 0.070 |
Why?
| | Phenotype | 3 | 2023 | 3074 | 0.070 |
Why?
| | Prevalence | 2 | 2025 | 2554 | 0.070 |
Why?
| | Emotions | 2 | 2022 | 538 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2439 | 0.070 |
Why?
| | Postoperative Period | 2 | 2017 | 329 | 0.060 |
Why?
| | Cohort Studies | 3 | 2022 | 5408 | 0.060 |
Why?
| | United States | 4 | 2025 | 13828 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1467 | 0.060 |
Why?
| | XYY Karyotype | 1 | 2025 | 21 | 0.060 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2025 | 15 | 0.060 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 72 | 0.060 |
Why?
| | Gonadoblastoma | 1 | 2024 | 6 | 0.060 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 69 | 0.060 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2024 | 27 | 0.060 |
Why?
| | Hypercalciuria | 1 | 2024 | 2 | 0.060 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2024 | 3 | 0.060 |
Why?
| | Mental Health | 2 | 2023 | 685 | 0.050 |
Why?
| | 17-alpha-Hydroxyprogesterone | 1 | 2023 | 3 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 3710 | 0.050 |
Why?
| | Vomiting | 1 | 2024 | 128 | 0.050 |
Why?
| | Cystatin C | 1 | 2023 | 65 | 0.050 |
Why?
| | Animals | 3 | 2021 | 35307 | 0.050 |
Why?
| | Headache | 1 | 2024 | 151 | 0.050 |
Why?
| | Sex Chromosomes | 1 | 2023 | 50 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2023 | 133 | 0.050 |
Why?
| | Phosphates | 1 | 2024 | 179 | 0.050 |
Why?
| | Aneuploidy | 1 | 2023 | 92 | 0.050 |
Why?
| | Virilism | 1 | 2022 | 5 | 0.050 |
Why?
| | Fever | 1 | 2024 | 298 | 0.050 |
Why?
| | Hydrocortisone | 1 | 2024 | 306 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 121 | 0.050 |
Why?
| | Sex Differentiation | 1 | 2021 | 10 | 0.050 |
Why?
| | Creatinine | 1 | 2023 | 491 | 0.050 |
Why?
| | Hirsutism | 1 | 2021 | 12 | 0.050 |
Why?
| | Karyotype | 1 | 2021 | 17 | 0.050 |
Why?
| | Alopecia | 1 | 2021 | 30 | 0.050 |
Why?
| | Chromosomes, Human, Y | 1 | 2021 | 20 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 14455 | 0.040 |
Why?
| | Mammary Glands, Human | 1 | 2021 | 64 | 0.040 |
Why?
| | Health Occupations | 1 | 2021 | 30 | 0.040 |
Why?
| | Mosaicism | 1 | 2021 | 71 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 279 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 207 | 0.040 |
Why?
| | Polymicrogyria | 1 | 2019 | 6 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1544 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2021 | 313 | 0.040 |
Why?
| | Canada | 1 | 2021 | 350 | 0.040 |
Why?
| | Laparoscopy | 1 | 2024 | 449 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1875 | 0.040 |
Why?
| | Physicians, Women | 1 | 2020 | 69 | 0.040 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 489 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 225 | 0.040 |
Why?
| | Minority Groups | 1 | 2020 | 249 | 0.040 |
Why?
| | Career Choice | 1 | 2020 | 206 | 0.040 |
Why?
| | Genitalia, Male | 1 | 2018 | 11 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 754 | 0.040 |
Why?
| | Esthetics | 1 | 2018 | 49 | 0.040 |
Why?
| | Surgery, Plastic | 1 | 2018 | 33 | 0.040 |
Why?
| | Universities | 1 | 2020 | 407 | 0.040 |
Why?
| | Social Media | 1 | 2020 | 137 | 0.040 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2017 | 29 | 0.030 |
Why?
| | Precision Medicine | 1 | 2020 | 386 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2020 | 299 | 0.030 |
Why?
| | Hormone Antagonists | 1 | 2016 | 32 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 744 | 0.030 |
Why?
| | Social Support | 1 | 2020 | 582 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1613 | 0.030 |
Why?
| | Prejudice | 1 | 2016 | 69 | 0.030 |
Why?
| | Gonadal Dysgenesis, 46,XY | 1 | 2015 | 1 | 0.030 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2015 | 6 | 0.030 |
Why?
| | Karyotyping | 1 | 2015 | 107 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 339 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 333 | 0.030 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.030 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 7 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 684 | 0.030 |
Why?
| | Human Growth Hormone | 1 | 2015 | 45 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2016 | 203 | 0.030 |
Why?
| | Thyrotropin | 1 | 2015 | 109 | 0.030 |
Why?
| | Hypogonadism | 1 | 2015 | 84 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 910 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2063 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2018 | 10199 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2636 | 0.030 |
Why?
| | WT1 Proteins | 1 | 2012 | 14 | 0.030 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 24 | 0.030 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 52 | 0.020 |
Why?
| | Genetic Testing | 1 | 2015 | 428 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1482 | 0.020 |
Why?
| | Physicians | 1 | 2020 | 859 | 0.020 |
Why?
| | Depression | 1 | 2020 | 1306 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 485 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2737 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2140 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 6391 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3233 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 820 | 0.020 |
Why?
| | Mass Screening | 1 | 2015 | 1149 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2669 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1446 | 0.010 |
Why?
| | Transcription Factors | 1 | 2012 | 1647 | 0.010 |
Why?
| | Mice | 1 | 2021 | 16915 | 0.010 |
Why?
|
|
Nokoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|